Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
CONMED Corporation Announces Second Quarter 2018 Financial Results
August 1, 2018 4:01 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (Nasdaq: CNMD) today announced financial results for the second quarter ended June 30, 2018.
Second Quarter 2018 Highlights
Sales of $212.8 million increased 7.9% year over year as reported and 7.4% in constant currency and as adjusted(1). Domestic revenue increased 9.6% year over year as reported and 12.0% as adjusted(1). International revenue increased 6.2% as reported and 2.9% in constant currency. Gross margin (GAAP) increased 150 basis points and adjusted gross margin increased 190 basis points year over year to... More


